156 related articles for article (PubMed ID: 36404484)
1. Incidence and clinical factors associated with ulceration in infantile hemangiomas.
Fernández Faith E; Shah SD; Braun M; Pope E; Lara-Corrales I; Witman PM; Harfmann K; Bradley F; Keesari R; Jackson K; Hallagan A; Frieden IJ
J Am Acad Dermatol; 2023 Feb; 88(2):414-420. PubMed ID: 36404484
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma.
Fernández Faith E; Shah S; Witman PM; Harfmann K; Bradley F; Blei F; Pope E; Alsumait A; Gupta D; Covelli I; Streicher JL; Cotton C; Tollefson M; Nguyen H; Hunt R; Moore-Clingenpeel M; Frieden IJ
JAMA Dermatol; 2021 May; 157(5):566-572. PubMed ID: 33787840
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of infantile hemangiomas with aggressive, persistent, and destructive ulceration.
Gautam A; Frieden IJ; Shah SD; Witman PM; Harfmann K; Bradley F; Blei F; Pope E; Alsumait A; Gupta D; Covelli I; Streicher JL; Cotton C; Tollefson M; Nguyen H; Hunt R; Buros A; Fernández Faith E
Pediatr Dermatol; 2023; 40(6):996-1002. PubMed ID: 37845188
[TBL] [Abstract][Full Text] [Related]
5. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
[TBL] [Abstract][Full Text] [Related]
6. Propranolol in the management of infantile hemangiomas: clinical response and predictors.
Balma-Mena A; Chakkittakandiyil A; Weinstein M; Lansang P; Ho N; Cammisuli S; Pope E
J Cutan Med Surg; 2012; 16(3):169-73. PubMed ID: 22713439
[TBL] [Abstract][Full Text] [Related]
7. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of periorbital infantile hemangiomas: Case series and literature review.
Sun LM; Xu Y; Xu MN; Wang M; Su Y; Yuan SM
Int J Pediatr Otorhinolaryngol; 2020 Sep; 136():110157. PubMed ID: 32544638
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas.
Mashiah J; Bar-Ilan E; Koren A; Friedman O; Zur E; Artzi O
Dermatology; 2020; 236(6):565-570. PubMed ID: 32653885
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of infantile hemangioma after termination of propranolol treatment.
Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
[TBL] [Abstract][Full Text] [Related]
11. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
[TBL] [Abstract][Full Text] [Related]
12. Is Routine Electrocardiography Necessary Before Initiation of Propranolol for Treatment of Infantile Hemangiomas?
Yarbrough KB; Tollefson MM; Krol AL; Leitenberger SL; Mann JA; MacArthur CJ
Pediatr Dermatol; 2016 Nov; 33(6):615-620. PubMed ID: 27599450
[TBL] [Abstract][Full Text] [Related]
13. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
14. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
[TBL] [Abstract][Full Text] [Related]
16. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
[TBL] [Abstract][Full Text] [Related]
17. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
18. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
19. Update on infantile hemangiomas.
Lee KC; Bercovitch L
Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
[TBL] [Abstract][Full Text] [Related]
20. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
